Biogen Completes Acquisition of RayThera Inc.

{
  "signal_id": "307d4f77-2aa9-8c65-b5a3-435640811a05",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-08-06T22:15:00+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/08/06/3340877/0/en/Biogen-Completes-Acquisition-of-RayThera-Inc.html",
    "title": "Biogen Completes Acquisition of RayThera Inc.",
    "excerpt": "CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecule therapies in immunology. The acquisition strengthens Biogen’s growing immunology portfolio, adding multiple assets that have potential to treat immune-mediated conditions across a range of indications. The lead program entered Phase 1 development in July 2026. “We are excited about the potential of these immunology assets as we continue to strengthen and diversify our pipeline for long-term growth,” said Priya Singhal, M.D., M.P.H., Executive Vice President and Head of Development at Biogen. “With the lead program now in Phase 1, this acquisition highlights strong execution on our open innovation model in sourcing external opportunities and reflects our continued investment in immunology as a strategic growth area.” About Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return...",
    "summary": "Biogen has completed its acquisition of RayThera Inc., a biotechnology company focused on immunology therapies.",
    "location": "Cambridge, Massachusetts, USA",
    "planning": false,
    "image_url": "https://ml.globenewswire.com/Resource/Download/80f9c524-3da2-4583-a763-0dad931fa182",
    "confidence": 0.95,
    "published_at": "2026-08-06T22:15:00Z",
    "location_data": [
      {
        "city": "Cambridge",
        "state": "Massachusetts",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-08-06",
    "article_sentence": "Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecule therapies in immunology.",
    "related_company_name": "RayThera Inc.",
    "related_company_domain": "raythera.com"
  }
}

curl https://signals.autobound.ai/v1/signals/307d4f77-2aa9-8c65-b5a3-435640811a05 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'